These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17109566)

  • 21. Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: an update review.
    Yeh YC; Ouyang WC
    Kaohsiung J Med Sci; 2012 Apr; 28(4):185-93. PubMed ID: 22453066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].
    Gillabert C; Desmeules J; Vogt-Ferrier N; Dayer P
    Rev Med Suisse; 2006 Apr; 2(61):970-5. PubMed ID: 16686329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study.
    Torrisi M; De Cola MC; Marra A; De Luca R; Bramanti P; Calabrò RS
    Psychogeriatrics; 2017 Mar; 17(2):103-107. PubMed ID: 27411501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
    Wightman R; Fielding J; Green S
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
    Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.
    Porsteinsson AP; Tariot PN; Jakimovich LJ; Kowalski N; Holt C; Erb R; Cox C
    Am J Geriatr Psychiatry; 2003; 11(4):434-40. PubMed ID: 12837672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenia and valproate.
    Citrome L
    Psychopharmacol Bull; 2003; 37 Suppl 2():74-88. PubMed ID: 15021863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.
    Konovalov S; Muralee S; Tampi RR
    Int Psychogeriatr; 2008 Apr; 20(2):293-308. PubMed ID: 18047764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divalproex sodium in the treatment of pediatric psychiatric disorders.
    Rana M; Khanzode L; Karnik N; Saxena K; Chang K; Steiner H
    Expert Rev Neurother; 2005 Mar; 5(2):165-76. PubMed ID: 15853487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divalproex in the treatment of migraine.
    Freitag FG
    Psychopharmacol Bull; 2003; 37 Suppl 2():98-115. PubMed ID: 15021865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.
    Kochar DK; Garg P; Bumb RA; Kochar SK; Mehta RD; Beniwal R; Rawat N
    QJM; 2005 Jan; 98(1):29-34. PubMed ID: 15625351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clozapine for behavioural and psychological symptoms of dementia].
    van Waalwijk MA; Schulte PFJ; Wetzels R
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
    Smith MC; Centorrino F; Welge JA; Collins MA
    Epilepsy Behav; 2004 Oct; 5(5):746-51. PubMed ID: 15380129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment of dementia.
    Schwarz S; Froelich L; Burns A
    Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.